CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 217 enrolled
Drug / intervention
Standard antidepressant therapy (SADT) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00564278
NCT00564278N/ACompleted
CompareCT.gov

Motivational Antidepressant Therapy for Hispanics

New York State Psychiatric Institute·interventional·Posted Nov 27, 2007·Updated May 19, 2021

In Brief

A clinical study evaluating Standard antidepressant therapy (SADT) and Motivational antidepressant therapy (MADT) for Depression. Completed, enrolled 217 participants across 1 site.

Detailed Summary

This study will evaluate the effectiveness of adding motivational interviewing to antidepressant treatment for major depressive disorder in Hispanic adults.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 27, 2007
Enrollment StartFeb 1, 2008
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 18.6 years ago

Interventions

Standard antidepressant therapy (SADT)drug

Treatment with medication will follow the Texas Medication Algorithm (TMA) for Depression. Antidepressant medications may include the following: citalopram (Celexa), escitalopram (Lexapro), paroxetine (Paxil CR), sertraline (Zoloft), venlafaxine XR (Effexor XR), bupropion SR (Wellbutrin SR), duloxetine (Cymbalta), nortriptyline (Pamelor), and mirtazapine (Remeron).

Motivational antidepressant therapy (MADT)behavioral

The same medication treatment for depression will be offered and supplemented with techniques from motivational interviewing.